About this item:

88 Views | 66 Downloads

Author Notes:

Nancy S. Ghanayem, MD, Medical College of Wisconsin, Children's Hospital of Wisconsin, Pediatrics, 9000 West Wisconsin Ave, PO Box 1997, Milwaukee, WI 53226, nancyg@mcw.edu.

This work is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute.

Subjects:

Research Funding:

Supported by Grants HL068269, HL068270, HL068279, HL068281, HL068285, HL068288, HL068290, HL068292, and HL085057 from the National Heart, Lung, and Blood Institute.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Cardiac & Cardiovascular Systems
  • Respiratory System
  • Surgery
  • Cardiovascular System & Cardiology
  • LEFT-HEART SYNDROME
  • BLALOCK-TAUSSIG SHUNT
  • PULMONARY-ARTERY CONDUIT
  • STAGE-I PALLIATION
  • RISK-FACTORS
  • OUTCOMES
  • DEATH
  • OPERATION
  • INFANTS
  • DISEASE

Interstage mortality after the Norwood procedure: Results of the multicenter Single Ventricle Reconstruction trial

Show all authors Show less authors

Tools:

Journal Title:

Journal of Thoracic and Cardiovascular Surgery

Volume:

Volume 144, Number 4

Publisher:

, Pages 896-906

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Objective: For infants with single ventricle malformations undergoing staged repair, interstage mortality is reported at 2% to 20%. The Single Ventricle Reconstruction trial randomized subjects with a single morphologic right ventricle undergoing a Norwood procedure to a modified Blalock-Taussig shunt (MBTS) or a right ventricle-to-pulmonary artery shunt (RVPAS). The aim o f this analysis was to explore the associations of interstage mortality and shunt type, and demographic, anatomic, and perioperative factors. Methods: Participants in the Single Ventricle Reconstruction trial who survived to discharge after the Norwood procedure were included (n = 426). Interstage mortality was defined as death postdischarge after the Norwood procedure and before the stage II procedure. Univariate analysis and multivariable logistic regression were performed adjusting for site. Results: Overall interstage mortality was 50 of 426 (12%) - 13 of 225 (6%) for RVPAS and 37 of 201 (18%) for MBTS (odds ratio [OR] for MBTS, 3.4; P < .001). When moderate to severe postoperative atrioventricular valve regurgitation (AVVR) was present, interstage mortality was similar between shunt types. Interstage mortality was independently associated with gestational age less than 37 weeks (OR, 3.9; P = .008), Hispanic ethnicity (OR, 2.6; P = .04), aortic atresia/mitral atresia (OR, 2.3; P = .03), greater number of post-Norwood complications (OR, 1.2; P = .006), census block poverty level (P = .003), and MBTS in subjects with no or mild postoperative AVVR (OR, 9.7; P < .001). Conclusions: Interstage mortality remains high at 12% and is increased with the MBTS compared with the RVPAS if postoperative AVVR is absent or mild. Preterm delivery, anatomic, and socioeconomic factors are also important. Avoiding preterm delivery when possible and close surveillance after Norwood hospitalization for infants with identified risk factors may reduce interstage mortality.

Copyright information:

© 2012 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Creative Commons License

Export to EndNote